Albert David Limited (BOM:524075)

Market Cap	4.80B
Revenue (ttm)	3.60B
Net Income (ttm)	404.41M
Shares Out	5.71M
EPS (ttm)	70.87
PE Ratio	11.86
Forward PE	n/a
Dividend	11.50 (1.37%)
Ex-Dividend Date	Aug 2, 2024

Volume	523
Average Volume	815
Open	871.10
Previous Close	879.90
Day's Range	842.60 - 871.15
52-Week Range	763.90 - 1,752.95
Beta	0.23
RSI	46.77
Earnings Date	May 9, 2025

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Pharmaceutical Preparations
• Founded: 1938
• Employees: 1,497
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524075

Financial Performance

In 2023, Albert David's revenue was 3.62 billion, an increase of 6.12% compared to the previous year's 3.42 billion. Earnings were 754.20 million, an increase of 108.49%.